Kot Prick Test Hal Allergy

Cat epithelial extract, the active ingredient in Kot Prick Test Hal Allergy, is an allergen extract presented as a skin test reagent for cutaneous use. It is employed to evaluate sensitization to cat allergens in individuals suspected of having cat‑related allergic disease. The preparation enables clinicians to perform standardized skin prick testing, facilitating accurate diagnosis of cat allergy.

GNH USA supplies Kot Prick Test Hal Allergy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory documentation to support global distribution.

Kot Prick Test Hal Allergy is used in the allergology field to identify IgE‑mediated sensitization to cat proteins. - Cat allergy diagnosis: confirms sensitization to cat epithelial allergens during skin prick testing. - Allergy work‑up: assists clinicians in differentiating cat‑related symptoms from other environmental triggers. - Pre‑treatment evaluation: helps determine suitability for allergen immunotherapy targeting cat allergens.

Skin prick testing with cat epithelial extract may cause transient local reactions and, rarely, systemic responses.

Common Side Effects: - Local wheal formation: small raised bump at the test site. - Redness (erythema) around the puncture. - Itching or mild discomfort at the application area. - Minor swelling of the surrounding skin. - Transient urticaria limited to the test site. - Temporary bruising from the lancet.

Serious or Rare Side Effects: - Systemic allergic reaction (anaphylaxis). - Generalized urticaria beyond the test site. - Angioedema affecting lips, tongue or airway. - Respiratory distress or bronchospasm. - Cardiovascular collapse or hypotension. - Severe dizziness or loss of consciousness.

Prior to performing a skin prick test with Kot Prick Test Hal Allergy, clinicians should consider several safety measures. - Patient selection: avoid testing in individuals with uncontrolled severe asthma. - Medication interference: antihistamines, corticosteroids, or immunosuppressants may suppress the skin response; adjust or discontinue as clinically appropriate. - Pregnancy: use only if the diagnostic benefit outweighs potential risk. - Skin condition: do not test on eczematous, infected, or damaged skin. - Emergency preparedness: have epinephrine and trained personnel ready to manage systemic reactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Cat epithelial extract may interact with medications that influence allergic responses or emergency treatment.

Major Interactions (Avoid): - Antihistamines: suppress skin test reactivity, leading to false‑negative results. - Beta‑blockers: increase severity of systemic reactions and may reduce effectiveness of epinephrine.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: may diminish wheal size, requiring careful interpretation. - Immunosuppressive agents: can alter immune response to the extract. - ACE inhibitors: may raise the risk of angioedema during a systemic reaction.